SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Dishman Pharmaceuticals & Chemicals

Dishman Pharmaceuticals & Chemicals

BSE: 532526 | NSE: DISHMAN | ISIN: INE353G01020 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Aug 24, 16:01
173.80
-2.85 (-1.61%)
VOLUME 125,800
AVERAGE VOLUME
5-Day 252,225
10-Day 251,206
30-Day 423,611
VOLUME SHOCKER
5-Day 252,225
10-Day 251,206
30-Day 423,611
Prev. Close
176.65
Open Price
174.65
Bid PRICE (QTY.)
173.80 (79)
Offer PRICE (Qty.)
173.80 (21)
VWAP 174.95
Market
Depth

Market Depth (25 Aug 2016)

BUY SELL
QTY PRICE PRICE QTY
122 173.60 174.00 2
17 173.55 174.20 1125
376 173.50 174.25 250
134 173.15 174.30 2025
268 173.05 174.40 225
4785 Total 15.31 K Total

Buy Qty

4785

Sell QTY

15.31 K

Today's Low/High 173.00 177.50
52 Wk Low/High 86.93 209.85
L/U Price Band 141.35 211.95
LIVE
NSE
Aug 24, 16:01
173.75
-3.15 (-1.78%)
VOLUME 729,344
AVERAGE VOLUME
5-Day 1,420,307
10-Day 1,364,622
30-Day 2,041,079
VOLUME SHOCKER
5-Day 1,420,307
10-Day 1,364,622
30-Day 2,041,079
Prev. Close
176.90
Open Price
177.05
Bid PRICE (QTY.)
173.75 (4849)
Offer PRICE (Qty.)
0.00 (0)
VWAP 174.86
Today's Low/High 173.00 177.80
52 Wk Low/High 86.78 209.90
L/U Price Band 141.55 212.25
Action in Dishman Pharmaceuticals & Chemicals

No recommendations so far.

What's your call on Dishman Pharma today?
Read 11 investor views

Consolidated
MARKET CAP (Rs Cr)
2,805.03
P/E
15.69
BOOK VALUE (Rs)
76.36
DIV (%)
100.00%
Market Lot
1
INDUSTRY P/E
27.86
EPS (TTM)
11.08
P/C
9.74
PRICE/BOOK
2.28
DIV YIELD.(%)
1.15%
FACE VALUE (Rs)
2.00
DELIVERABLES (%)
51.01 new
DELIVERY AVERAGES
3-Day 35.68%
5-Day 40.92%
8-Day 36.54%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track Dishman Pharma on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

19 July 2016

buy

Ceat Jul Fut

Entry Price (Rs)

884.00

Exit Price (Rs)

893.00

Gain (Rs)

9.00

buy

DrReddysLabs Jul Fut

Entry Price (Rs)

3,580.00

Exit Price (Rs)

3,613.00

Gain (Rs)

33.00

sell

Glenmark Jul Fut

Entry Price (Rs)

847.00

Exit Price (Rs)

836.00

Gain (Rs)

11.00

buy

BajajAuto Jul Fut

Entry Price (Rs)

2,741.00

Exit Price (Rs)

2,759.00

Gain (Rs)

18.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 104.50 174.65  
High Price 107.70 177.50  
Low Price 90.70 173.00  
Last Price 92.58 173.80 87.73
Volume 536,322 125,800 -76.54
Simple Moving Averages
Days BSE NSE
30 156.36 156.45
50 149.06 149.14
150 158.62 158.66
200 161.23 161.28

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Dishman Pharma

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
 Standalone Jun'16 Mar'16 Dec'15
Sep'15
Net Sales 83.71 136.31 118.56 97.29
Other Income 4.94 1.08 2.46 49.13
PBDIT 33.13 57.11 43.09 30.75
Net Profit 8.42 23.19 16.11 39.85

Annual Report

Download in PDF format 2015 |2014 |2013 |2012 |2011 |2010
Balance Sheet
Mar'15
(In Rs Cr)
Total Share Capital 16.14
Net Worth 836.43
Total Debt 505.55
Net Block 693.61
Investments 223.36
Total Assets 1,341.97
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 770.65 1.07 940.40 706.40 185,476.49
Lupin 1521.10 -2.16 2127.00 1294.05 68,598.73
Dr Reddys Labs 3039.10 1.04 4382.95 2750.00 51,900.53
Aurobindo Pharm 787.55 6.96 891.50 618.00 46,085.03
Cipla 565.90 1.97 704.75 458.25 45,476.32
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 16Dec' 15Sep' 15Jun' 15
Promoter61.4061.4061.4061.40
Public (FII + DII)38.6038.6038.6038.60
Others0.000.000.000.00
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Bhadr - Raj Chambers, Swastik Cross Road,,Navrangpura
City
Ahmedabad
State
Gujarat
Pin Code
380009
Tel. No.
079-26443053 079-26445807
Fax No.
079-26420198
REGISTRARS
Name
Link Intime India Pvt. Ltd.
Address
C-33, Pannalal Silk Mills Compound, LBS Marg, Bhandup (W)
City
Mumbai - 400078
State
Maharashtra
Tel. No.
022-25963838, 25946970
Fax No.
022-25946969
MANAGEMENT
Name
Designation
Janmejay R Vyas
Chairman & Managing Director
Arpit J Vyas
Managing Director & CFO
Deohooti J Vyas
Whole Time Director
Mark C Griffiths
Director & Global CEO
Sanjay S Majmudar
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Unichem Laboratories Recommended on Mar 29th 2016

Recommended price 219.00  |  Peak from reco 318.85 45.79%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Dishman Pharma

Dishman Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,805.03 crore.

The company management includes Janmejay R Vyas - Chairman & Managing Director, Arpit J Vyas - Managing Director & CFO, Deohooti J Vyas - Whole Time Director, Mark C Griffiths - Director & Global CEO, Sanjay S Majmudar - Director, Ashok C Gandhi - Director, Subir Kumar Das - Director, Rajendra S Shah - Addnl. & Ind.Director.

It is listed on the BSE with a BSE Code of 532526 and the NSE with an NSE Code of DISHMAN.

Its Registered office is at Bhadr - Raj Chambers, Swastik Cross Road,,Navrangpura Ahmedabad,Gujarat - 380009.

Their Registrars are Link Intime India Pvt. Ltd.

Quick Links for Dishman Pharmaceuticals & Chemicals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Dishman Pharma